Asset Details
Do you wish to reserve the book?
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Do you wish to request the book?
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
2015
Overview
Neglected tropical diseases cause significant morbidity and mortality and are a source of poverty in endemic countries. Only a few drugs are available to treat diseases such as leishmaniasis, Chagas' disease, human African trypanosomiasis and malaria. Since drug development is lengthy and expensive, a drug repurposing strategy offers an attractive fast-track approach to speed up the process. A set of 100 registered drugs with drug repositioning potential for neglected diseases was assembled and tested in vitro against four protozoan parasites associated with the aforementioned diseases. Several drugs and drug classes showed in vitro activity in those screening assays. The results are critically reviewed and discussed in the perspective of a follow-up drug repositioning strategy where R&D has to be addressed with limited resources.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Animals
/ Antiprotozoal Agents - pharmacology
/ Antiprotozoal Agents - therapeutic use
/ Chagas Disease - drug therapy
/ Diseases
/ Drug Evaluation, Preclinical
/ Drug Repositioning - methods
/ Drugs
/ Humans
/ Leishmania donovani - drug effects
/ Leishmaniasis - drug therapy
/ Macrophages, Peritoneal - drug effects
/ Macrophages, Peritoneal - parasitology
/ Malaria
/ Mice
/ Neglected Diseases - drug therapy
/ Plasmodium falciparum - drug effects
/ Poverty
/ Protozoa
/ R&D
/ Trypanosoma brucei rhodesiense - drug effects
/ Trypanosoma cruzi - drug effects
